MD Anderson Cancer Center and Sanofi announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune therapies, for patients with cancer.
The Hackensack Meridian Center for Discovery and Innovation and Merck are investigating drugs for treatment of COVID-19.
Seth D. Cohen was appointed to the newly created position of regional director of Oncology Services for the RWJBarnabas Health Southern Region.
Leading cancer fighting organizations from across the United States submitted a letter to President Donald Trump and his administration, urging that the decision to withdraw from the World Health Organization be reconsidered.
Marc Theoret, Julia Beaver, Tamy Kim and Laleh Amiri-Kordestani were named to new positions at FDA.
Markus Müschen was named the inaugural director of the Center of Molecular and Cellular Oncology at Yale Cancer Center and Smilow Cancer Hospital. Müschen will also be appointed Arthur H. and Isabel Bunker Professor of Medicine (hematology) and professor of immunobiology at Yale School of Medicine.
Debra Friedman, E. Bronson Ingram Chair of Pediatric Oncology, was named associate director of community science and health outcomes at Vanderbilt-Ingram Cancer Center.
Janice M. Mehnert, an expert in phase I therapeutics and the treatment of skin malignancies, was named associate director for clinical research at NYU Langone Health's Perlmutter Cancer Center.
Yale Cancer Center researchers were awarded a $2.8 million grant from NCI to evaluate and model cytokine signaling related to immunotherapy for cancer.
Thermo Fisher Scientific and Chugai Pharmaceutical Co. Ltd., have signed a companion diagnostic agreement and applied to the Ministry of Health, Labour and Welfare to expand the use of the Oncomine Dx Target Test in Japan.
